↓ Skip to main content

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

Overview of attention for article published in Journal of Translational Medicine, July 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter
1 X user
patent
9 patents
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
211 Dimensions

Readers on

mendeley
163 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity
Published in
Journal of Translational Medicine, July 2010
DOI 10.1186/1479-5876-8-71
Pubmed ID
Authors

Chrystelle Brignone, Maya Gutierrez, Fawzia Mefti, Etienne Brain, Rosana Jarcau, Frédérique Cvitkovic, Nabil Bousetta, Jacques Medioni, Joseph Gligorov, Caroline Grygar, Manon Marcu, Frédéric Triebel

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 163 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
United States 1 <1%
Canada 1 <1%
Australia 1 <1%
Unknown 159 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 36 22%
Student > Ph. D. Student 28 17%
Student > Bachelor 16 10%
Student > Master 13 8%
Student > Doctoral Student 11 7%
Other 21 13%
Unknown 38 23%
Readers by discipline Count As %
Medicine and Dentistry 33 20%
Agricultural and Biological Sciences 27 17%
Biochemistry, Genetics and Molecular Biology 24 15%
Immunology and Microbiology 18 11%
Pharmacology, Toxicology and Pharmaceutical Science 8 5%
Other 12 7%
Unknown 41 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 August 2023.
All research outputs
#2,281,494
of 22,807,037 outputs
Outputs from Journal of Translational Medicine
#370
of 3,991 outputs
Outputs of similar age
#8,437
of 94,217 outputs
Outputs of similar age from Journal of Translational Medicine
#2
of 12 outputs
Altmetric has tracked 22,807,037 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,991 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 94,217 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.